| 789848 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: clinical outcomes and translational biomarker analyses |
2022-01-01 |
10.1136/jitc-2021-003853 |
Friedman Claire F, Spencer Christine, Cabanski Christopher R, Panageas Katherine S, Wells Daniel K, Ribas Antoni, Tawbi Hussein, Tsai Katy, Postow Michael, Shoushtari Alexander, Chapman Paul, Karakunnel Joyson, Bucktrout Samantha, Gherardini Pier, Hollmann Travis J, Chen Richard O, Callahan Margaret, LaVallee Theresa, Ibrahim Ramy, Wolchok Jedd |
| 789847 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Improved prognosis and evidence of enhanced immunogenicity in tumor and circulation of high-risk melanoma patients with unknown primary |
2022-01-01 |
10.1136/jitc-2021-004310 |
Tarhini Ahmad A, Lee Sandra J, Tan Aik-Choon, El Naqa Issam M, Stephen Hodi F, Butterfield Lisa H, LaFramboise William A, Storkus Walter J, Karunamurthy Arivarasan D, Conejo-Garcia Jose R, Hwu Patrick, Streicher Howard, Sondak Vernon K, Kirkwood John M |
| 789846 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinoma |
2022-01-01 |
10.1136/jitc-2021-003198 |
Spassova Ivelina, Ugurel Selma, Kubat Linda, Zimmer Lisa, Terheyden Patrick, Mohr Annalena, Björn Andtback Hannah, Villabona Lisa, Leiter Ulrike, Eigentler Thomas, Loquai Carmen, Hassel Jessica C, Gambichler Thilo, Haferkamp Sebastian, Mohr Peter, Pfoehler Claudia, Heinzerling Lucie, Gutzmer Ralf, Utikal Jochen S, Horny Kai, Schildhaus Hans-Ulrich, Habermann Daniel, Hoffmann Daniel, Schadendorf Dirk, Becker Jürgen Christian |
| 789845 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Efficacy of pembrolizumab and comprehensive CD274/PD-L1 profiles in patients previously treated with chemoradiation therapy as radical treatment in bladder cancer |
2022-01-01 |
10.1136/jitc-2021-003868 |
Nishimura Kazuki, Nishio Kyosuke, Hirosuna Kensuke, Komura Kazumasa, Hayashi Takuo, Fukuokaya Wataru, Ura Ayako, Uchimoto Taizo, Nakamura Ko, Fukushima Tatsuo, Yano Yusuke, Takahashi Nobushige, Nakamori Keita, Kinoshita Shoko, Matsunaga Tomohisa, Tsutsumi Takeshi, Tsujino Takuya, Taniguchi Kohei, Tanaka Tomohito, Uehara Hirofumi, Takahara Kiyoshi, Inamoto Teruo, Hirose Yoshinobu, Kimura Takahiro, Egawa Shin, Azuma Haruhito |
| 789844 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity |
2022-01-01 |
10.1136/jitc-2021-003717 |
Abe Shinya, Nagata Hiroshi, Crosby Erika J, Inoue Yoshiyuki, Kaneko Kensuke, Liu Cong-Xiao, Yang Xiao, Wang Tao, Acharya Chaitanya R, Agarwal Pankaj, Snyder Joshua, Gwin William, Morse Michael A, Zhong Pei, Lyerly Herbert Kim, Osada Takuya |
| 789843 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
CD161 expression and regulation defines rapidly responding effector CD4+ T cells associated with improved survival in HPV16-associated tumors |
2022-01-01 |
10.1136/jitc-2021-003995 |
Duurland Chantal L, Santegoets Saskia J, Abdulrahman Ziena, Loof Nikki M, Sturm Gregor, Wesselink Tom H, Arens Ramon, Boekestijn Sanne, Ehsan Ilina, van Poelgeest Mariette I E, Finotello Francesca, Hackl Hubert, Trajanoski Zlatko, ten Dijke Peter, Braud Veronique M, Welters Marij J P, van der Burg Sjoerd H |
| 789842 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Short-course neoadjuvant in situ vaccination for murine melanoma |
2022-01-01 |
10.1136/jitc-2021-003586 |
Aiken Taylor J, Komjathy David, Rodriguez Matthew, Stuckwisch Ashley, Feils Arika, Subbotin Vladimir, Birstler Jen, Gillies Stephen D, Rakhmilevich Alexander L, Erbe Amy K, Sondel Paul M |
| 789841 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Association of selected (immune-related) adverse events and outcome in two adjuvant phase III trials, Checkmate-238 and EORTC1325/KEYNOTE-054 |
2022-01-01 |
10.1136/jitc-2021-004272 |
Eggermont Alexander, Kicinski Michal, Suciu Stefan |
| 789840 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Response to: Association of selected (immune-related) adverse events and outcome in two adjuvant phase III trials, Checkmate-238 and EORTC1325/KEYNOTE-054 by Eggermont et al |
2022-01-01 |
10.1136/jitc-2021-004347 |
Weber Jeffrey, Mandala Mario, Ascierto Paolo Antonio, Larkin James |
| 789839 |
ALEXANDRIA ENGINEERING JOURNAL : AEJ |
Selection of heavy machinery for earthwork activities: A multi-objective optimization approach using a genetic algorithm |
2022-01-01 |
10.1016/j.aej.2022.01.010 |
Shehadeh Ali, Alshboul Odey, Tatari Omer, Alzubaidi Mohammad A., Hamed El-Sayed Salama Ahmed |
